TLK1 and cancer: In addition to the aforementioned established role of TLK1 in the repair of cyclo-pyrimidine dimers (CPDs), there is emerging evidence for a role in cisplatin-induced ICLs and base adducts, particularly inferred through the effects observed in knock-down studies of cancer cells.